The U.S. Food and Drug Administration cleared Olympus Corporation of the Americas to sell a revised version of a medical device used to examine a patient’s internal organs. Olympus revised the device, called a duodenoscope, after it was linked to outbreaks of a potentially deadly bacteria.
User ID / Email / Password is case sensitive
To inquire about group subscriptions or an enterprise site license for your organization, contact Tracy Bumba
Get Essential Business News
1 Year Print & Digital
1 Year Print +Digital + Data Joe (BOL)
Monthly Digital Only
First time registering your paid subscription? Click here
Having trouble with login?
Please contact [email protected].